the Effect of Implanon on Menstrual Patterns

NCT ID: NCT06936436

Last Updated: 2025-04-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-31

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate whether the timing of postpartum Implanon insertion (immediately postpartum, early postpartum, or late postpartum) affects menstrual patterns

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Etonogestrel implants (Implanon) are widely used for postpartum contraception. However, the timing of insertion may influence menstrual patterns, including irregular bleeding, amenorrhea, and prolonged bleeding episodes. Despite the increasing use of immediate postpartum contraception, there is limited research on how the timing of Implanon insertion affects menstrual cycle regulation.
* Furthermore, lactation and hormonal changes postpartum may modify the bleeding patterns in women using Implanon, with breastfeeding women experiencing a higher likelihood of amenorrhea due to prolactin-induced suppression of ovulation.
* This study aims to fill these gaps by systematically comparing menstrual outcomes based on timing of Implanon insertion postpartum

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstrual Irregularities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implanon (Etonogestrel)

implanon is a long acting ,reversible contraceptive implants used to prevent pregnancy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Postpartum women opting for Implanon as contraception.
* No contraindications to hormonal contraception.

Exclusion Criteria

* . Women with known bleeding disorders.
* Use of other hormonal contraceptives during the study period.
* Postpartum complications such as severe infections or retained products of conception
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kholoud Khalid Kamal

OBSTETRICS AND GYNECOLOGY RESIDENT

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

AHMED MOHAMED ABBAS, PROF.DR

Role: STUDY_CHAIR

Assiut University

MOHAMED SAYED ABDELLAH, PROF.DR

Role: STUDY_CHAIR

Assiut University

ALAA AHMED MAKHLOUF, DR

Role: STUDY_CHAIR

Assiut University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

kholoud khalid KAMAL

Role: CONTACT

01013224377

References

Explore related publications, articles, or registry entries linked to this study.

Mazza D, Harrison C, Taft A, Brijnath B, Britt H, Hobbs M, Stewart K, Hussainy S. Current contraceptive management in Australian general practice: an analysis of BEACH data. Med J Aust. 2012 Jul 16;197(2):110-4. doi: 10.5694/mja11.11599.

Reference Type BACKGROUND
PMID: 22794058 (View on PubMed)

Richters J, Grulich AE, de Visser RO, Smith AM, Rissel CE. Sex in Australia: contraceptive practices among a representative sample of women. Aust N Z J Public Health. 2003;27(2):210-6. doi: 10.1111/j.1467-842x.2003.tb00810.x.

Reference Type BACKGROUND
PMID: 14696713 (View on PubMed)

. Product information: Implanon NXT, Schering-Plough Pty Ltd, 12 November 2010

Reference Type BACKGROUND

Product information: Implanon® Implant, Organon (Australia) Pty Ltd, 19 March 2008.

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

effect of implanon

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postpartum Family Planning
NCT03844633 TERMINATED PHASE4
Immediate Postplacental IUD Insertion
NCT02169869 TERMINATED NA